60 related articles for article (PubMed ID: 2166841)
1. Augmented antiproliferative effect of tumor necrosis factor (TNF), lymphotoxin and glycyrrhizin in combined use with diethyldithiocarbamate on Meth A tumor cells in vitro.
Mashiba H; Matsunaga K
Jpn J Exp Med; 1990 Apr; 60(2):67-71. PubMed ID: 2166841
[TBL] [Abstract][Full Text] [Related]
2. Attempt to augment the anti-proliferative effect of recombinant human lymphotoxin in combined use with anti-tumor antibody-diethyldithiocarbamate conjugates.
Mashiba H; Matsunaga K
Eur Cytokine Netw; 1991; 2(3):195-9. PubMed ID: 1654145
[TBL] [Abstract][Full Text] [Related]
3. [Augmentation of TNF- and lymphotoxin-mediated cytotoxic effect in the combined use of ACNU and involvement of oxygen free radicals].
Matsunaga K; Mashiba H
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):452-8. PubMed ID: 2321976
[TBL] [Abstract][Full Text] [Related]
4. Device for intracellular increase of oxygen free radicals and inhibition of MethA tumour cell proliferation: in vitro and in vivo studies.
Mashiba H; Matsunaga K
Int J Tissue React; 1988; 10(5):273-80. PubMed ID: 2855073
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of cytostatic effect of recombinant human lymphotoxin and involvement of glutathione redox cycle.
Matsunaga K; Mashiba H
Eur Cytokine Netw; 1992; 3(3):307-11. PubMed ID: 1498261
[TBL] [Abstract][Full Text] [Related]
6. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice.
Granger GA; Masunaka I; Averbook B; Kobayashi M; Fitzgerald M; Yamamoto R
J Biol Response Mod; 1988 Oct; 7(5):488-97. PubMed ID: 3263472
[TBL] [Abstract][Full Text] [Related]
7. Augmented inhibition of tumor cell proliferation in the combined use of disulfiram with ascorbic acid and the involvement of oxygen free radicals.
Mashiba H; Matsunaga K
Jpn J Exp Med; 1990 Aug; 60(4):209-14. PubMed ID: 2292808
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of cytotoxic activity of recombinant human tumor necrosis factor (rHu-TNF) by recombinant human interferon-gamma (rHu-IFN-gamma).
Taguchi T; Kimoto Y; Tanji Y; Abe S; Nakano K; Sohmura Y
J Biol Response Mod; 1987 Dec; 6(6):599-609. PubMed ID: 3131488
[TBL] [Abstract][Full Text] [Related]
9. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
Browning J; Ribolini A
J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
[TBL] [Abstract][Full Text] [Related]
10. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.
Börset M; Medvedev AE; Sundan A; Espevik T
Cytokine; 1996 Jun; 8(6):430-8. PubMed ID: 8818539
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
[TBL] [Abstract][Full Text] [Related]
12. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species.
Pober JS; Lapierre LA; Stolpen AH; Brock TA; Springer TA; Fiers W; Bevilacqua MP; Mendrick DL; Gimbrone MA
J Immunol; 1987 May; 138(10):3319-24. PubMed ID: 3494766
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor and lymphotoxin gene expression in human tumor cell lines.
Krönke M; Hensel G; Schlüter C; Scheurich P; Schütze S; Pfizenmaier K
Cancer Res; 1988 Oct; 48(19):5417-21. PubMed ID: 3262009
[TBL] [Abstract][Full Text] [Related]
14. [Antiproliferative effect of tumor necrosis factor-alpha on human glioblastoma cells].
Kato T
Hokkaido Igaku Zasshi; 1995 Mar; 70(2):261-74. PubMed ID: 7774879
[TBL] [Abstract][Full Text] [Related]
15. Effects of growth factors on the antiproliferative activity of tumor necrosis factors.
Sugarman BJ; Lewis GD; Eessalu TE; Aggarwal BB; Shepard HM
Cancer Res; 1987 Feb; 47(3):780-6. PubMed ID: 3802082
[TBL] [Abstract][Full Text] [Related]
16. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines.
Morinaga Y; Suzuki H; Takatsuki F; Akiyama Y; Taniyama T; Matsushima K; Onozaki K
J Immunol; 1989 Dec; 143(11):3538-42. PubMed ID: 2584706
[TBL] [Abstract][Full Text] [Related]
17. The functional role of 55- and 75-kDa tumour necrosis factor receptors in human polymorphonuclear cells in vitro.
Abe Y; Osuka Y; Nakata T; Kashu Y; Kimura S
Cytokine; 1995 Jan; 7(1):39-49. PubMed ID: 7749065
[TBL] [Abstract][Full Text] [Related]
18. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
[TBL] [Abstract][Full Text] [Related]
19. Immunotargeting approach utilizing production of oxygen free radicals.
Mashiba H; Matsunaga K
Cancer Lett; 1990 Dec; 55(3):183-8. PubMed ID: 2175248
[TBL] [Abstract][Full Text] [Related]
20. Regulation of B cell maturation and differentiation. I. Suppression of pokeweed mitogen-induced B cell differentiation by tumor necrosis factor (TNF).
Kashiwa H; Wright SC; Bonavida B
J Immunol; 1987 Mar; 138(5):1383-90. PubMed ID: 2949015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
